awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
90717-0	Consultation note	Find	Pt	{Setting}	Doc	Heart failure+Transplant cardiology	DOC.ONTOLOGY	2	Heart failure+Transplant cardiology Consult note	HF+TC Consult note	null	ACTIVE	2.65	2.65
90718-8	During the past Mo, how often did you eat hot or cold cereals	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat hot or cold cereals	null	null	ACTIVE	2.65	2.65
90719-6	During the past Mo, how often did you drink regular soda or pop that contains sugar	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you drink regular soda or pop that contains sugar	null	null	ACTIVE	2.65	2.65
9072-0	Fat intake	MRat	24H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Fat intake 24 hour	Fat intake 24h	null	ACTIVE	1.0i	2.48
90720-4	During the past Mo, how often did you drink coffee or tea that had sugar or honey added to it	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you drink coffee or tea that had sugar or honey added to it	null	null	ACTIVE	2.65	2.65
90721-2	During the past Mo, how often did you eat a green leafy or lettuce salad, with or without other vegetables	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat a green leafy or lettuce salad, with or without other vegetables	null	null	ACTIVE	2.65	2.65
90722-0	During the past Mo, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes	null	null	ACTIVE	2.65	2.65
90723-8	During the past Mo, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad	null	null	ACTIVE	2.65	2.65
90724-6	During the past Mo, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans	null	null	ACTIVE	2.65	2.65
90725-3	During the past Mo, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet	null	null	ACTIVE	2.65	2.65
90726-1	During the past Mo, how often did you eat pizza	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat pizza	null	null	ACTIVE	2.65	2.65
90727-9	During the past Mo, how often did you eat any kind of cheese	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat any kind of cheese	null	null	ACTIVE	2.65	2.65
90728-7	During the past Mo, how often did you eat red meat, such as beef, pork, ham, or sausage	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat red meat, such as beef, pork, ham, or sausage	null	null	ACTIVE	2.65	2.65
90729-5	During the past Mo, how often did you eat ice cream or other frozen desserts	NRat	1Mo	^Patient	Qn	null	SURVEY.NHANES	4	During the past month, how often did you eat ice cream or other frozen desserts	null	null	ACTIVE	2.65	2.65
90730-3	Self-perception of body weight	Find	Pt	^Patient	Ord	null	H&P.HX	2	Self-perception of body weight	Self-perception of body wgt	null	ACTIVE	2.65	2.65
90731-1	Frequency of creatine used to improve muscle mass or strength in past Y	NRat	1Y	^Patient	Ord	null	H&P.HX	2	Frequency of creatine used to improve muscle mass or strength in past year	Freq creatine used in past Y	null	ACTIVE	2.65	2.65
90732-9	Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past Y	NRat	1Y	^Patient	Ord	null	H&P.HX	2	Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past year	Freq DHEA, A4 or hGH in past Y	null	ACTIVE	2.65	2.65
90733-7	Frequency of anabolic steroids used to improve muscle mass or strength in past Y	NRat	1Y	^Patient	Ord	null	H&P.HX	2	Frequency of anabolic steroids used to improve muscle mass or strength in past year	Freq anabolic steroids used in past Y	null	ACTIVE	2.65	2.65
90734-5	Body weight change goal	Find	Pt	^Patient	Nom	null	H&P.HX	2	Body weight change goal	Body weight change goal	null	ACTIVE	2.65	2.65
90735-2	Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag Panel	-	Pt	Bld	-	null	PANEL.CELLMARK	1	PNH GPI-Linked WBC and RBC Ag Panel - Blood	PNH GPI-Lkd WBC + RBC Ag Pnl Bld	null	ACTIVE	2.65	2.65
90736-0	Cells.CD14-FLAER-/100 cells.CD33	NFr	Pt	Bld	Qn	null	CELLMARK	1	CD14-FLAER- cells/100 cells.CD33 (Monocytes) in Blood	CD14-FLAER- cells/100 cells.CD33 NFr Bld	null	ACTIVE	2.65	2.72
90737-8	Cells.CD24-FLAER-/100 cells.CD15	NFr	Pt	Bld	Qn	null	CELLMARK	1	CD24-FLAER- cells/100 cells.CD15 (Neutrophils) in Blood	CD24-FLAER- cells/100 CD15 cells NFr Bld	null	ACTIVE	2.65	2.72
9073-8	Potassium intake	Sub	Pt	^Patient	Qn	Estimated	IO_IN_SALTS+CALS	2	Potassium intake Estimated	Potassium intake Est	null	ACTIVE	1.0i	2.48
90738-6	Erythrocytes.CD59 complete loss/100 Cells.235a	NFr	Pt	Bld	Qn	null	CELLMARK	1	Erythrocytes.CD59 complete loss/100 erythrocytes in Blood	RBC CD59 complete loss NFr	null	ACTIVE	2.65	2.65
90739-4	Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag	Imp	Pt	Bld	Nar	null	CELLMARK	1	PHH GPI-Linked WBC and RBC Ag [Interpretation] in Blood Narrative	PNH GPI-Linked WBC + RBC Ag Bld-Imp	null	ACTIVE	2.65	2.65
90740-2	Aggressive prostate cancer risk	Likelihood	Pt	Ser/Plas	Qn	Calculated.4Kscore	CHEM	1	Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore	Aggr PC risk SerPl Calculated.4Kscore	null	ACTIVE	2.65	2.73
90741-0	Parathyrin.1-84	MCnc	Pt	Ser/Plas	Qn	IA	CHEM	1	Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay	Parathyrin.1-84 SerPl IA-mCnc	null	ACTIVE	2.65	2.65
90742-8	Bovine Mullerian inhibiting substance	MCnc	Pt	Ser/Plas	Qn	IA	FERT	1	Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay	Bovine MIS SerPl IA-mCnc	null	ACTIVE	2.65	2.65
90743-6	CYBB gene full & NCF1 gene c.75_76delGT analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH.MUT	1	CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method	CYBB full + NCF1 c.75_76delGT Bld/T	null	ACTIVE	2.65	2.65
90744-4	Youth Risk Behavior Survey - body weight panel	-	Pt	^Patient	-	CDC	PANEL.SURVEY.CDC	4	Youth Risk Behavior Survey - body weight panel [CDC]	null	null	ACTIVE	2.65	2.67
90745-1	Surgical procedures requiring active SNF care	Find	Pt	^Patient	Nom	CMS Assessment	SURVEY.CMS	4	Surgical procedures requiring active SNF care [CMS Assessment]	null	null	ACTIVE	2.66	2.66
9074-6	Potassium intake	Sub	Pt	^Patient	Qn	Measured	IO_IN_SALTS+CALS	2	Potassium intake Measured	Potassium intake Measured	null	ACTIVE	1.0i	2.48
90746-9	5-fluoro ADB-M7	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method	5-F ADB-M7 Ur Cfm-mCnc	null	ACTIVE	2.65	2.65
90747-7	MDMB-FUBINACA-M1	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	MDMB-FUBINACA-M1 [Mass/volume] in Urine by Confirmatory method	MDMB-FUBINACA-M1 Ur Cfm-mCnc	null	ACTIVE	2.65	2.65
90748-5	Atomoxetine	MCnc	Pt	Saliva	Qn	Confirm	DRUG/TOX	1	Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method	Atomoxetine Sal Cfm-mCnc	null	ACTIVE	2.65	2.65
90749-3	4-Hydroxyatomoxetine	MCnc	Pt	Saliva	Qn	Confirm	DRUG/TOX	1	4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method	4OH-atomoxetine Sal Cfm-mCnc	null	ACTIVE	2.65	2.65
90750-1	O-Nortramadol	MCnc	Pt	Saliva	Qn	Confirm	DRUG/TOX	1	O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method	O-nortramadol Sal Cfm-mCnc	null	ACTIVE	2.65	2.65
90751-9	Note	Find	Pt	Adult day care center	Doc	Social worker	DOC.ONTOLOGY	2	Social worker Adult day care center Note	SW ADCC Note	null	ACTIVE	2.65	2.65
90752-7	Note	Find	Pt	{Setting}	Doc	Community health care.social worker	DOC.ONTOLOGY	2	Community health care Social worker Note	CHC SW Note	null	ACTIVE	2.65	2.65
9075-3	Potassium intake	SRat	1H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Potassium intake 1 hour	Potassium intake 1h	null	ACTIVE	1.0i	2.48
90753-5	Note	Find	Pt	{Setting}	Doc	Multi-specialty program.social worker	DOC.ONTOLOGY	2	Multi-specialty program Social worker Note	Multi-spec prog SW Note	null	ACTIVE	2.65	2.65
90754-3	Note	Find	Pt	{Setting}	Doc	Mental health.social worker	DOC.ONTOLOGY	2	Mental health Social worker Note	MH SW Note	null	ACTIVE	2.65	2.65
90755-0	Note	Find	Pt	Long term care facility	Doc	Palliative care.social worker	DOC.ONTOLOGY	2	Palliative care Social worker Long term care facility Note	Palliative care SW LTC fac Note	null	ACTIVE	2.65	2.65
90756-8	Note	Find	Pt	{Setting}	Doc	Palliative care.social worker	DOC.ONTOLOGY	2	Palliative care Social worker Note	Palliative care SW Note	null	ACTIVE	2.65	2.65
90757-6	Note	Find	Pt	Hospital	Doc	Physical medicine and rehab.social worker	DOC.ONTOLOGY	2	Physical medicine and rehabilitation Social worker Hospital Note	PM+R SW Hosp Note	null	ACTIVE	2.65	2.65
90758-4	Note	Find	Pt	Outpatient hospital	Doc	Physical medicine and rehab.social worker	DOC.ONTOLOGY	2	Physical medicine and rehabilitation Social worker Outpatient hospital Note	PM+R SW Outpt Hosp Note	null	ACTIVE	2.65	2.65
90759-2	Note	Find	Pt	{Setting}	Doc	Primary care.social worker	DOC.ONTOLOGY	2	Primary care Social worker Note	Primary care SW Note	null	ACTIVE	2.65	2.65
907-6	Blood group antigens present	Prid	Pt	^BPU	Nom	null	BLDBK	1	Blood group antigens present [Identifier] in Blood product unit	Antigens Present BPU	null	ACTIVE	1.0	2.26
90760-0	Note	Find	Pt	{Setting}	Doc	Addiction medicine.social worker	DOC.ONTOLOGY	2	Addiction medicine Social worker Note	Addiction med SW Note	null	ACTIVE	2.65	2.65
9076-1	Potassium intake	SRat	8H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Potassium intake 8 hour	Potassium intake 8h	null	ACTIVE	1.0i	2.48
90761-8	PROMIS item bank - applied cognitive - general concerns - version 1.0	-	Pt	^Patient	-	PROMIS	PANEL.SURVEY.PROMIS	4	PROMIS item bank - applied cognitive - general concerns - version 1.0	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.65	2.65
90762-6	PROMIS applied cognitive - general concerns - version 1.0 T-Score	Tscore	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS applied cognitive - general concerns - version 1.0 T-score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.65	2.65
90763-4	HEDIS 2019-2020 Value Set - Chlamydia Tests	-	Pt	^Patient	-	null	PANEL.HEDIS	1	HEDIS 2019-2020 Value Set - Chlamydia Tests	HEDIS 2019-20 Chlamydia	null	DISCOURAGED	2.65	2.69
90764-2	HEDIS 2019 Value Set - Toxoplasma Antibody	-	Pt	^Patient	-	null	PANEL.HEDIS	1	HEDIS 2019 Value Set - Toxoplasma Antibody	HEDIS 2019 Toxoplasma Ab	null	DISCOURAGED	2.65	2.67
90765-9	HEDIS 2019 Value Set - Rh	-	Pt	^Patient	-	null	PANEL.HEDIS	1	HEDIS 2019 Value Set - Rh	HEDIS 2019 Rh	null	DISCOURAGED	2.65	2.67
90766-7	HEDIS 2019 Value Sets	-	Pt	^Patient	-	null	PANEL.HEDIS	1	HEDIS 2019 Value Sets	HEDIS 2019 Value Sets	null	DISCOURAGED	2.65	2.67
90767-5	Pregnancy summary	Find	Pt	^Patient	Doc	null	DOC.MISC	2	Pregnancy summary Document	Pregnancy summary Doc	null	ACTIVE	2.65	2.65
90768-3	Donor blood study	Find	Pt	Bld^Donor	Doc	null	DOC.MISC	2	Donor blood study	Donor bld study	null	ACTIVE	2.65	2.72
90769-1	Plan of care note	Find	Pt	{Setting}	Doc	Heart failure	DOC.ONTOLOGY	2	Heart failure Plan of care note	Heart failure Plan of care note	null	ACTIVE	2.65	2.65
90770-9	Initial evaluation note	Find	Pt	{Setting}	Doc	Heart failure	DOC.ONTOLOGY	2	Heart failure Initial evaluation note	Heart failure Initial eval note	null	ACTIVE	2.65	2.65
90771-7	Consultation note	Find	Pt	{Setting}	Doc	Heart failure	DOC.ONTOLOGY	2	Heart failure Consult note	Heart failure Consult note	null	ACTIVE	2.65	2.65
90772-5	Progress note	Find	Pt	{Setting}	Doc	Heart failure	DOC.ONTOLOGY	2	Heart failure Progress note	Heart failure Prog note	null	ACTIVE	2.65	2.73
90773-3	Note	Find	Pt	Telephone encounter	Doc	Heart failure	DOC.ONTOLOGY	2	Heart failure Telephone encounter Note	Heart failure Phone Note	null	ACTIVE	2.65	2.65
90774-1	Conference note	Find	Pt	{Setting}	Doc	Heart failure.team	DOC.ONTOLOGY	2	Heart failure Team Conference note	Heart failure Team Conf eval note	null	ACTIVE	2.65	2.65
90775-8	Disease severity level	Find	Pt	^Patient	Ord	Reported	SURVEY.GNHLTH	4	Disease severity level [Reported]	null	null	ACTIVE	2.65	2.65
90776-6	HEDIS 2019 Value Set - Rubella Antibody	-	Pt	^Patient	-	null	PANEL.HEDIS	1	HEDIS 2019 Value Set - Rubella Antibody	HEDIS 2019 Rubella Ab	null	DISCOURAGED	2.65	2.67
90777-4	HEDIS 2019 Value Set - Cytomegalovirus Antibody	-	Pt	^Patient	-	null	PANEL.HEDIS	1	HEDIS 2019 Value Set - Cytomegalovirus Antibody	HEDIS 2019 CMV Ab	null	DISCOURAGED	2.65	2.67
90778-2	Personal pronouns	Type	Pt	^Patient	Nom	Reported	CLIN	2	Personal pronouns - Reported	Personal pronoun Reported	null	ACTIVE	2.65	2.66
9077-9	Potassium intake	SRat	10H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Potassium intake 10 hour	Potassium intake 10h	null	ACTIVE	1.0i	2.48
90779-0	Adalimumab Ab	ACnc	Pt	Ser	Qn	IA	SERO	1	Adalimumab Ab [Units/volume] in Serum by Immunoassay	Adalimumab Ab Ser IA-aCnc	null	ACTIVE	2.65	2.68
90780-8	inFLIXimab Ab	ACnc	Pt	Ser	Qn	IA	SERO	1	inFLIXimab Ab [Units/volume] in Serum by Immunoassay	inFLIXimab Ab Ser IA-aCnc	null	ACTIVE	2.65	2.68
90781-6	N,N'-Dimethylarginine	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	N,N'-dimethylarginine [Mass/volume] in Serum or Plasma	N,N'-dimethylarginine SerPl-mCnc	null	ACTIVE	2.65	2.65
90782-4	F2-Isoprostanes	MCnc	Pt	Urine	Qn	null	CHEM	1	F2-Isoprostanes [Mass/volume] in Urine	F2-IsoPs Ur-mCnc	null	ACTIVE	2.65	2.65
90783-2	F2-Isoprostanes/Creatinine	MRto	Pt	Urine	Qn	null	CHEM	1	F2-Isoprostanes/Creatinine [Mass Ratio] in Urine	F2-IsoPs/Creat Ur	null	ACTIVE	2.65	2.65
90784-0	Cystinuria panel	-	Pt	Urine	-	null	PANEL.CHEM	1	Cystinuria panel - Urine	Cystinuria Pnl Ur	null	ACTIVE	2.65	2.65
90785-7	Cystinuria panel	-	24H	Urine	-	null	PANEL.CHEM	1	Cystinuria panel - 24 hour Urine	Cystinuria Pnl 24h Ur	null	ACTIVE	2.65	2.65
90786-5	Note	Find	Pt	{Setting}	Doc	Dentistry.attending	DOC.ONTOLOGY	2	Dentistry Attending Note	Dentistry Attend Note	null	ACTIVE	2.65	2.65
9078-7	Potassium intake	SRat	12H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Potassium intake 12 hour	Potassium intake 12h	null	ACTIVE	1.0i	2.48
90787-3	Note	Find	Pt	{Setting}	Doc	Dentistry.resident	DOC.ONTOLOGY	2	Dentistry Resident Note	Dentistry Res Note	null	ACTIVE	2.65	2.65
90788-1	Note	Find	Pt	{Setting}	Doc	Optometry.resident	DOC.ONTOLOGY	2	Optometry Resident Note	Optometry Res Note	null	ACTIVE	2.65	2.65
90789-9	Note	Find	Pt	{Setting}	Doc	Psychology.intern	DOC.ONTOLOGY	2	Psychology Intern Note	Psychology Intern Note	null	ACTIVE	2.65	2.65
90790-7	Note	Find	Pt	{Setting}	Doc	Podiatry.resident	DOC.ONTOLOGY	2	Podiatry Resident Note	Podiatry Res Note	null	ACTIVE	2.65	2.65
90791-5	Note	Find	Pt	{Setting}	Doc	Physical therapy.resident	DOC.ONTOLOGY	2	Physical therapy Resident Note	PT Res Note	null	ACTIVE	2.65	2.65
90792-3	Preoperative evaluation and management note	Find	Pt	{Setting}	Doc	Podiatry.attending	DOC.ONTOLOGY	2	Podiatry Attending Preoperative evaluation and management note	Podiatry Attend Pre-op note	null	ACTIVE	2.65	2.65
90793-1	Note	Find	Pt	{Setting}	Doc	Podiatry.attending	DOC.ONTOLOGY	2	Podiatry Attending Note	Podiatry Attend Note	null	ACTIVE	2.65	2.65
90794-9	Vedolizumab & Vedolizumab Ab Panel	MCnc	Pt	Ser/Plas	Qn	null	PANEL.DRUG/TOX	1	Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma	Vedol + Vedol Ab Pnl SerPl-mCnc	null	ACTIVE	2.65	2.65
9079-5	Protein intake	Mass	Pt	^Patient	Qn	Estimated	IO_IN_SALTS+CALS	2	Protein intake Estimated	Protein intake Est	null	ACTIVE	1.0i	2.48
90795-6	Levothyroxine absorption panel	-	Pt	Ser/Plas	Qn	null	PANEL.CHAL	1	Levothyroxine absorption panel - Serum or Plasma	Levothyroxine absorption pnl SerPl	null	ACTIVE	2.65	2.65
90796-4	Thyroxine^1H post dose levothyroxine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hours post dose levothyroxine	T4 1h p levo SerPl-mCnc	null	ACTIVE	2.65	2.65
90797-2	Thyroxine^2H post dose levothyroxine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Thyroxine (T4) [Mass/volume] in Serum or Plasma --2 hours post dose levothyroxine	T4 2h p levo SerPl-mCnc	null	ACTIVE	2.65	2.65
90798-0	Thyroxine^3H post dose levothyroxine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Thyroxine (T4) [Mass/volume] in Serum or Plasma --3 hours post dose levothyroxine	T4 3h p levo SerPl-mCnc	null	ACTIVE	2.65	2.65
90799-8	Thyroxine^4H post dose levothyroxine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Thyroxine (T4) [Mass/volume] in Serum or Plasma --4 hours post dose levothyroxine	T4 4h p levo SerPl-mCnc	null	ACTIVE	2.65	2.65
90800-4	Thyroxine^6H post dose levothyroxine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Thyroxine (T4) [Mass/volume] in Serum or Plasma --6 hours post dose levothyroxine	T4 6h p levo SerPl-mCnc	null	ACTIVE	2.65	2.65
90801-2	Thyrotropin^6H post dose levothyroxine	ACnc	Pt	Ser/Plas	Qn	null	CHAL	1	Thyrotropin [Units/volume] in Serum or Plasma --6 hours post dose levothyroxine	TSH 6h p levo SerPl-aCnc	null	ACTIVE	2.65	2.65
90802-0	Medication volume of distribution	Vol	Pt	^Patient	Qn	Calculated	MEDS	2	Medication volume of distribution Calculated	Med Vd Calc	null	ACTIVE	2.65	2.65
9080-3	Protein intake	Mass	Pt	^Patient	Qn	Measured	IO_IN_SALTS+CALS	2	Protein intake Measured	Protein intake Measured	null	ACTIVE	1.0i	2.48
90803-8	Peak concentration post XXX challenge - baseline concentration increment	MCncDiff	Pt	Ser/Plas	Qn	Calculated	DRUG/TOX	1	Post-challenge peak - baseline concentration increment [Mass concentration difference] in Serum or Plasma by calculation	Conc increment SerPl Calc-MCDiff	null	ACTIVE	2.65	2.65
90804-6	Levothyroxine absorption	MFr	Pt	Ser/Plas	Qn	Calculated	CHAL	1	Levothyroxine absorption in Serum or Plasma by calculation	Levothyroxine absorption MFr SerPl Calc	null	ACTIVE	2.65	2.65
90805-3	Vedolizumab^trough	MCnc	Pt	Ser/Plas	Qn	LC/MS/MS	DRUG/TOX	1	Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough	Vedolizumab Trough SerPl LC/MS/MS-mCnc	null	ACTIVE	2.65	2.65
90806-1	Candida albicans DNA	PrThr	Pt	Ser	Ord	Probe.amp.tar	MICRO	1	Candida albicans DNA [Presence] in Serum by NAA with probe detection	C albicans DNA Ser Ql NAA+probe	null	ACTIVE	2.65	2.65

90717-0

Consultation note

Find

Pt

{Setting}

Doc

Heart failure+Transplant cardiology

DOC.ONTOLOGY

2

Heart failure+Transplant cardiology Consult note

HF+TC Consult note

null

ACTIVE

2.65

90718-8

During the past Mo, how often did you eat hot or cold cereals

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat hot or cold cereals

null

ACTIVE

2.65

90719-6

During the past Mo, how often did you drink regular soda or pop that contains sugar

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you drink regular soda or pop that contains sugar

null

ACTIVE

2.65

9072-0

Fat intake

MRat

24H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Fat intake 24 hour

Fat intake 24h

null

ACTIVE

1.0i

2.48

90720-4

During the past Mo, how often did you drink coffee or tea that had sugar or honey added to it

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you drink coffee or tea that had sugar or honey added to it

null

ACTIVE

2.65

90721-2

During the past Mo, how often did you eat a green leafy or lettuce salad, with or without other vegetables

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat a green leafy or lettuce salad, with or without other vegetables

null

ACTIVE

2.65

90722-0

During the past Mo, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes

null

ACTIVE

2.65

90723-8

During the past Mo, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad

null

ACTIVE

2.65

90724-6

During the past Mo, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans

null

ACTIVE

2.65

90725-3

During the past Mo, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet

null

ACTIVE

2.65

90726-1

During the past Mo, how often did you eat pizza

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat pizza

null

ACTIVE

2.65

90727-9

During the past Mo, how often did you eat any kind of cheese

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat any kind of cheese

null

ACTIVE

2.65

90728-7

During the past Mo, how often did you eat red meat, such as beef, pork, ham, or sausage

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat red meat, such as beef, pork, ham, or sausage

null

ACTIVE

2.65

90729-5

During the past Mo, how often did you eat ice cream or other frozen desserts

NRat

1Mo

^Patient

Qn

null

SURVEY.NHANES

4

During the past month, how often did you eat ice cream or other frozen desserts

null

ACTIVE

2.65

90730-3

Self-perception of body weight

Find

Pt

^Patient

Ord

null

H&P.HX

2

Self-perception of body weight

Self-perception of body wgt

null

ACTIVE

2.65

90731-1

Frequency of creatine used to improve muscle mass or strength in past Y

NRat

1Y

^Patient

Ord

null

H&P.HX

2

Frequency of creatine used to improve muscle mass or strength in past year

Freq creatine used in past Y

null

ACTIVE

2.65

90732-9

Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past Y

NRat

1Y

^Patient

Ord

null

H&P.HX

2

Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past year

Freq DHEA, A4 or hGH in past Y

null

ACTIVE

2.65

90733-7

Frequency of anabolic steroids used to improve muscle mass or strength in past Y

NRat

1Y

^Patient

Ord

null

H&P.HX

2

Frequency of anabolic steroids used to improve muscle mass or strength in past year

Freq anabolic steroids used in past Y

null

ACTIVE

2.65

90734-5

Body weight change goal

Find

Pt

^Patient

Nom

null

H&P.HX

2

Body weight change goal

null

ACTIVE

2.65

90735-2

Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag Panel

-

Pt

Bld

-

null

PANEL.CELLMARK

1

PNH GPI-Linked WBC and RBC Ag Panel - Blood

PNH GPI-Lkd WBC + RBC Ag Pnl Bld

null

ACTIVE

2.65

90736-0

Cells.CD14-FLAER-/100 cells.CD33

NFr

Pt

Bld

Qn

null

CELLMARK

1

CD14-FLAER- cells/100 cells.CD33 (Monocytes) in Blood

CD14-FLAER- cells/100 cells.CD33 NFr Bld

null

ACTIVE

2.65

2.72

90737-8

Cells.CD24-FLAER-/100 cells.CD15

NFr

Pt

Bld

Qn

null

CELLMARK

1

CD24-FLAER- cells/100 cells.CD15 (Neutrophils) in Blood

CD24-FLAER- cells/100 CD15 cells NFr Bld

null

ACTIVE

2.65

2.72

9073-8

Potassium intake

Sub

Pt

^Patient

Qn

Estimated

IO_IN_SALTS+CALS

2

Potassium intake Estimated

Potassium intake Est

null

ACTIVE

1.0i

2.48

90738-6

Erythrocytes.CD59 complete loss/100 Cells.235a

NFr

Pt

Bld

Qn

null

CELLMARK

1

Erythrocytes.CD59 complete loss/100 erythrocytes in Blood

RBC CD59 complete loss NFr

null

ACTIVE

2.65

90739-4

Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag

Imp

Pt

Bld

Nar

null

CELLMARK

1

PHH GPI-Linked WBC and RBC Ag [Interpretation] in Blood Narrative

PNH GPI-Linked WBC + RBC Ag Bld-Imp

null

ACTIVE

2.65

90740-2

Aggressive prostate cancer risk

Likelihood

Pt

Ser/Plas

Qn

Calculated.4Kscore

CHEM

1

Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore

Aggr PC risk SerPl Calculated.4Kscore

null

ACTIVE

2.65

2.73

90741-0

Parathyrin.1-84

MCnc

Pt

Ser/Plas

Qn

IA

CHEM

1

Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay

Parathyrin.1-84 SerPl IA-mCnc

null

ACTIVE

2.65

90742-8

Bovine Mullerian inhibiting substance

MCnc

Pt

Ser/Plas

Qn

IA

FERT

1

Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay

Bovine MIS SerPl IA-mCnc

null

ACTIVE

2.65

90743-6

CYBB gene full & NCF1 gene c.75_76delGT analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH.MUT

1

CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method

CYBB full + NCF1 c.75_76delGT Bld/T

null

ACTIVE

2.65

90744-4

Youth Risk Behavior Survey - body weight panel

-

Pt

^Patient

-

CDC

PANEL.SURVEY.CDC

4

Youth Risk Behavior Survey - body weight panel [CDC]

null

ACTIVE

2.65

2.67

90745-1

Surgical procedures requiring active SNF care

Find

Pt

^Patient

Nom

CMS Assessment

SURVEY.CMS

4

Surgical procedures requiring active SNF care [CMS Assessment]

null

ACTIVE

2.66

9074-6

Potassium intake

Sub

Pt

^Patient

Qn

Measured

IO_IN_SALTS+CALS

2

Potassium intake Measured

null

ACTIVE

1.0i

2.48

90746-9

5-fluoro ADB-M7

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method

5-F ADB-M7 Ur Cfm-mCnc

null

ACTIVE

2.65

90747-7

MDMB-FUBINACA-M1

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

MDMB-FUBINACA-M1 [Mass/volume] in Urine by Confirmatory method

MDMB-FUBINACA-M1 Ur Cfm-mCnc

null

ACTIVE

2.65

90748-5

Atomoxetine

MCnc

Pt

Saliva

Qn

Confirm

DRUG/TOX

1

Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method

Atomoxetine Sal Cfm-mCnc

null

ACTIVE

2.65

90749-3

4-Hydroxyatomoxetine

MCnc

Pt

Saliva

Qn

Confirm

DRUG/TOX

1

4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method

4OH-atomoxetine Sal Cfm-mCnc

null

ACTIVE

2.65

90750-1

O-Nortramadol

MCnc

Pt

Saliva

Qn

Confirm

DRUG/TOX

1

O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method

O-nortramadol Sal Cfm-mCnc

null

ACTIVE

2.65

90751-9

Note

Find

Pt

Adult day care center

Doc

Social worker

DOC.ONTOLOGY

2

Social worker Adult day care center Note

SW ADCC Note

null

ACTIVE

2.65

90752-7

Note

Find

Pt

{Setting}

Doc

Community health care.social worker

DOC.ONTOLOGY

2

Community health care Social worker Note

CHC SW Note

null

ACTIVE

2.65

9075-3

Potassium intake

SRat

1H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Potassium intake 1 hour

Potassium intake 1h

null

ACTIVE

1.0i

2.48

90753-5

Note

Find

Pt

{Setting}

Doc

Multi-specialty program.social worker

DOC.ONTOLOGY

2

Multi-specialty program Social worker Note

Multi-spec prog SW Note

null

ACTIVE

2.65

90754-3

Note

Find

Pt

{Setting}

Doc

Mental health.social worker

DOC.ONTOLOGY

2

Mental health Social worker Note

MH SW Note

null

ACTIVE

2.65

90755-0

Note

Find

Pt

Long term care facility

Doc

Palliative care.social worker

DOC.ONTOLOGY

2

Palliative care Social worker Long term care facility Note

Palliative care SW LTC fac Note

null

ACTIVE

2.65

90756-8

Note

Find

Pt

{Setting}

Doc

Palliative care.social worker

DOC.ONTOLOGY

2

Palliative care Social worker Note

Palliative care SW Note

null

ACTIVE

2.65

90757-6

Note

Find

Pt

Hospital

Doc

Physical medicine and rehab.social worker

DOC.ONTOLOGY

2

Physical medicine and rehabilitation Social worker Hospital Note

PM+R SW Hosp Note

null

ACTIVE

2.65

90758-4

Note

Find

Pt

Outpatient hospital

Doc

Physical medicine and rehab.social worker

DOC.ONTOLOGY

2

Physical medicine and rehabilitation Social worker Outpatient hospital Note

PM+R SW Outpt Hosp Note

null

ACTIVE

2.65

90759-2

Note

Find

Pt

{Setting}

Doc

Primary care.social worker

DOC.ONTOLOGY

2

Primary care Social worker Note

Primary care SW Note

null

ACTIVE

2.65

907-6

Blood group antigens present

Prid

Pt

^BPU

Nom

null

BLDBK

1

Blood group antigens present [Identifier] in Blood product unit

Antigens Present BPU

null

ACTIVE

1.0

2.26

90760-0

Note

Find

Pt

{Setting}

Doc

Addiction medicine.social worker

DOC.ONTOLOGY

2

Addiction medicine Social worker Note

Addiction med SW Note

null

ACTIVE

2.65

9076-1

Potassium intake

SRat

8H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Potassium intake 8 hour

Potassium intake 8h

null

ACTIVE

1.0i

2.48

90761-8

PROMIS item bank - applied cognitive - general concerns - version 1.0

-

Pt

^Patient

-

PROMIS

PANEL.SURVEY.PROMIS

4

PROMIS item bank - applied cognitive - general concerns - version 1.0

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.65

90762-6

PROMIS applied cognitive - general concerns - version 1.0 T-Score

Tscore

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS applied cognitive - general concerns - version 1.0 T-score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.65

90763-4

HEDIS 2019-2020 Value Set - Chlamydia Tests

-

Pt

^Patient

-

null

PANEL.HEDIS

1

HEDIS 2019-2020 Value Set - Chlamydia Tests

HEDIS 2019-20 Chlamydia

null

DISCOURAGED

2.65

2.69

90764-2

HEDIS 2019 Value Set - Toxoplasma Antibody

-

Pt

^Patient

-

null

PANEL.HEDIS

1

HEDIS 2019 Value Set - Toxoplasma Antibody

HEDIS 2019 Toxoplasma Ab

null

DISCOURAGED

2.65

2.67

90765-9

HEDIS 2019 Value Set - Rh

-

Pt

^Patient

-

null

PANEL.HEDIS

1

HEDIS 2019 Value Set - Rh

HEDIS 2019 Rh

null

DISCOURAGED

2.65

2.67

90766-7

HEDIS 2019 Value Sets

-

Pt

^Patient

-

null

PANEL.HEDIS

1

HEDIS 2019 Value Sets

null

DISCOURAGED

2.65

2.67

90767-5

Pregnancy summary

Find

Pt

^Patient

Doc

null

DOC.MISC

2

Pregnancy summary Document

Pregnancy summary Doc

null

ACTIVE

2.65

90768-3

Donor blood study

Find

Pt

Bld^Donor

Doc

null

DOC.MISC

2

Donor blood study

Donor bld study

null

ACTIVE

2.65

2.72

90769-1

Plan of care note

Find

Pt

{Setting}

Doc

Heart failure

DOC.ONTOLOGY

2

Heart failure Plan of care note

null

ACTIVE

2.65

90770-9

Initial evaluation note

Find

Pt

{Setting}

Doc

Heart failure

DOC.ONTOLOGY

2

Heart failure Initial evaluation note

Heart failure Initial eval note

null

ACTIVE

2.65

90771-7

Consultation note

Find

Pt

{Setting}

Doc

Heart failure

DOC.ONTOLOGY

2

Heart failure Consult note

null

ACTIVE

2.65

90772-5

Progress note

Find

Pt

{Setting}

Doc

Heart failure

DOC.ONTOLOGY

2

Heart failure Progress note

Heart failure Prog note

null

ACTIVE

2.65

2.73

90773-3

Note

Find

Pt

Telephone encounter

Doc

Heart failure

DOC.ONTOLOGY

2

Heart failure Telephone encounter Note

Heart failure Phone Note

null

ACTIVE

2.65

90774-1

Conference note

Find

Pt

{Setting}

Doc

Heart failure.team

DOC.ONTOLOGY

2

Heart failure Team Conference note

Heart failure Team Conf eval note

null

ACTIVE

2.65

90775-8

Disease severity level

Find

Pt

^Patient

Ord

Reported

SURVEY.GNHLTH

4

Disease severity level [Reported]

null

ACTIVE

2.65

90776-6

HEDIS 2019 Value Set - Rubella Antibody

-

Pt

^Patient

-

null

PANEL.HEDIS

1

HEDIS 2019 Value Set - Rubella Antibody

HEDIS 2019 Rubella Ab

null

DISCOURAGED

2.65

2.67

90777-4

HEDIS 2019 Value Set - Cytomegalovirus Antibody

-

Pt

^Patient

-

null

PANEL.HEDIS

1

HEDIS 2019 Value Set - Cytomegalovirus Antibody

HEDIS 2019 CMV Ab

null

DISCOURAGED

2.65

2.67

90778-2

Personal pronouns

Type

Pt

^Patient

Nom

Reported

CLIN

2

Personal pronouns - Reported

Personal pronoun Reported

null

ACTIVE

2.65

2.66

9077-9

Potassium intake

SRat

10H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Potassium intake 10 hour

Potassium intake 10h

null

ACTIVE

1.0i

2.48

90779-0

Adalimumab Ab

ACnc

Pt

Ser

Qn

IA

SERO

1

Adalimumab Ab [Units/volume] in Serum by Immunoassay

Adalimumab Ab Ser IA-aCnc

null

ACTIVE

2.65

2.68

90780-8

inFLIXimab Ab

ACnc

Pt

Ser

Qn

IA

SERO

1

inFLIXimab Ab [Units/volume] in Serum by Immunoassay

inFLIXimab Ab Ser IA-aCnc

null

ACTIVE

2.65

2.68

90781-6

N,N'-Dimethylarginine

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

N,N'-dimethylarginine [Mass/volume] in Serum or Plasma

N,N'-dimethylarginine SerPl-mCnc

null

ACTIVE

2.65

90782-4

F2-Isoprostanes

MCnc

Pt

Urine

Qn

null

CHEM

1

F2-Isoprostanes [Mass/volume] in Urine

F2-IsoPs Ur-mCnc

null

ACTIVE

2.65

90783-2

F2-Isoprostanes/Creatinine

MRto

Pt

Urine

Qn

null

CHEM

1

F2-Isoprostanes/Creatinine [Mass Ratio] in Urine

F2-IsoPs/Creat Ur

null

ACTIVE

2.65

90784-0

Cystinuria panel

-

Pt

Urine

-

null

PANEL.CHEM

1

Cystinuria panel - Urine

Cystinuria Pnl Ur

null

ACTIVE

2.65

90785-7

Cystinuria panel

-

24H

Urine

-

null

PANEL.CHEM

1

Cystinuria panel - 24 hour Urine

Cystinuria Pnl 24h Ur

null

ACTIVE

2.65

90786-5

Note

Find

Pt

{Setting}

Doc

Dentistry.attending

DOC.ONTOLOGY

2

Dentistry Attending Note

Dentistry Attend Note

null

ACTIVE

2.65

9078-7

Potassium intake

SRat

12H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Potassium intake 12 hour

Potassium intake 12h

null

ACTIVE

1.0i

2.48

90787-3

Note

Find

Pt

{Setting}

Doc

Dentistry.resident

DOC.ONTOLOGY

2

Dentistry Resident Note

Dentistry Res Note

null

ACTIVE

2.65

90788-1

Note

Find

Pt

{Setting}

Doc

Optometry.resident

DOC.ONTOLOGY

2

Optometry Resident Note

Optometry Res Note

null

ACTIVE

2.65

90789-9

Note

Find

Pt

{Setting}

Doc

Psychology.intern

DOC.ONTOLOGY

2

Psychology Intern Note

null

ACTIVE

2.65

90790-7

Note

Find

Pt

{Setting}

Doc

Podiatry.resident

DOC.ONTOLOGY

2

Podiatry Resident Note

Podiatry Res Note

null

ACTIVE

2.65

90791-5

Note

Find

Pt

{Setting}

Doc

Physical therapy.resident

DOC.ONTOLOGY

2

Physical therapy Resident Note

PT Res Note

null

ACTIVE

2.65

90792-3

Preoperative evaluation and management note

Find

Pt

{Setting}

Doc

Podiatry.attending

DOC.ONTOLOGY

2

Podiatry Attending Preoperative evaluation and management note

Podiatry Attend Pre-op note

null

ACTIVE

2.65

90793-1

Note

Find

Pt

{Setting}

Doc

Podiatry.attending

DOC.ONTOLOGY

2

Podiatry Attending Note

Podiatry Attend Note

null

ACTIVE

2.65

90794-9

Vedolizumab & Vedolizumab Ab Panel

MCnc

Pt

Ser/Plas

Qn

null

PANEL.DRUG/TOX

1

Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

Vedol + Vedol Ab Pnl SerPl-mCnc

null

ACTIVE

2.65

9079-5

Protein intake

Mass

Pt

^Patient

Qn

Estimated

IO_IN_SALTS+CALS

2

Protein intake Estimated

Protein intake Est

null

ACTIVE

1.0i

2.48

90795-6

Levothyroxine absorption panel

-

Pt

Ser/Plas

Qn

null

PANEL.CHAL

1

Levothyroxine absorption panel - Serum or Plasma

Levothyroxine absorption pnl SerPl

null

ACTIVE

2.65

90796-4

Thyroxine^1H post dose levothyroxine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hours post dose levothyroxine

T4 1h p levo SerPl-mCnc

null

ACTIVE

2.65

90797-2

Thyroxine^2H post dose levothyroxine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Thyroxine (T4) [Mass/volume] in Serum or Plasma --2 hours post dose levothyroxine

T4 2h p levo SerPl-mCnc

null

ACTIVE

2.65

90798-0

Thyroxine^3H post dose levothyroxine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Thyroxine (T4) [Mass/volume] in Serum or Plasma --3 hours post dose levothyroxine

T4 3h p levo SerPl-mCnc

null

ACTIVE

2.65

90799-8

Thyroxine^4H post dose levothyroxine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Thyroxine (T4) [Mass/volume] in Serum or Plasma --4 hours post dose levothyroxine

T4 4h p levo SerPl-mCnc

null

ACTIVE

2.65

90800-4

Thyroxine^6H post dose levothyroxine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Thyroxine (T4) [Mass/volume] in Serum or Plasma --6 hours post dose levothyroxine

T4 6h p levo SerPl-mCnc

null

ACTIVE

2.65

90801-2

Thyrotropin^6H post dose levothyroxine

ACnc

Pt

Ser/Plas

Qn

null

CHAL

1

Thyrotropin [Units/volume] in Serum or Plasma --6 hours post dose levothyroxine

TSH 6h p levo SerPl-aCnc

null

ACTIVE

2.65

90802-0

Medication volume of distribution

Vol

Pt

^Patient

Qn

Calculated

MEDS

2

Medication volume of distribution Calculated

Med Vd Calc

null

ACTIVE

2.65

9080-3

Protein intake

Mass

Pt

^Patient

Qn

Measured

IO_IN_SALTS+CALS

2

Protein intake Measured

null

ACTIVE

1.0i

2.48

90803-8

Peak concentration post XXX challenge - baseline concentration increment

MCncDiff

Pt

Ser/Plas

Qn

Calculated

DRUG/TOX

1

Post-challenge peak - baseline concentration increment [Mass concentration difference] in Serum or Plasma by calculation

Conc increment SerPl Calc-MCDiff

null

ACTIVE

2.65

90804-6

Levothyroxine absorption

MFr

Pt

Ser/Plas

Qn

Calculated

CHAL

1

Levothyroxine absorption in Serum or Plasma by calculation

Levothyroxine absorption MFr SerPl Calc

null

ACTIVE

2.65

90805-3

Vedolizumab^trough

MCnc

Pt

Ser/Plas

Qn

LC/MS/MS

DRUG/TOX

1

Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough

Vedolizumab Trough SerPl LC/MS/MS-mCnc

null

ACTIVE

2.65

90806-1

Candida albicans DNA

PrThr

Pt

Ser

Ord

Probe.amp.tar

MICRO

1

Candida albicans DNA [Presence] in Serum by NAA with probe detection

C albicans DNA Ser Ql NAA+probe

null

ACTIVE

2.65